Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
EOS INC.
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
EOS INC.
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
EOS INC.
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
EOS INC.
CIK:
0001651958
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.25.1
Consolidated Statements of Operation and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]
Net sales
$ 296,852
$ 652,547
Cost of sales
(102,975)
(365,282)
Gross profit
193,877
287,265
Selling, general and administrative expenses
(966,486)
(2,208,876)
(Loss) from operations
(772,609)
(1,921,611)
Other income (expense)
Interest expense
(6,859)
(4,512)
Other income
147,532
3,871
Total other income (expense)
140,673
(641)
Loss before income tax provision
(631,936)
(1,922,252)
Income tax benefits (expenses)
0
10,093
Net Loss
(631,936)
(1,912,159)
Other Comprehensive Loss:
Net loss attributable to non-controlling interests
(4,782)
(41,294)
Net loss attributable to EOS and subsidiaries
(627,154)
(1,870,865)
Foreign currency translation adjustment, net of tax
(44,434)
(91,532)
Comprehensive loss
$ (676,370)
$ (2,003,691)
Net loss per share:
Basic
$ 0
$ (0.01)
Diluted
$ 0
$ (0.01)
Weighted average number of common shares:
Basic
219,639,094
182,376,491
Diluted
219,639,094
182,376,491
v3.25.1
Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities
Net loss
$ (631,936)
$ (1,912,159)
Adjustments to reconcile net income to net cash provided by operating activities
Provision for doubtful debts
0
272,843
Reversal of provision for doubtful debts
(148,452)
0
Depreciation
833
3,257
Amortization of right-of-use asset
32,042
26,296
Impairments of assets
27
1,060,300
Inventories written off
4,392
0
Stock based compensation
41,019
1,231
Changes in assets and liabilities
Decrease in accounts receivable
86,463
88,021
Increase in inventory
(37,754)
(20,006)
Decrease in advance to suppliers
5,415
89,547
Decrease (increase) in security deposits and other assets
18,140
(2,721)
Increase in accounts payable
9,761
0
Increase in accrued expenses
343,189
243,517
Increase (decrease) in advances from customers
(4,083)
13,261
Decrease in income tax payable
(3,756)
(1,805)
Decrease in operating lease liabilities
(32,617)
(26,296)
Net cash used in operating activities
(317,317)
(164,714)
Cash flows from investing activity
Purchase of equipments
(1,834)
(19,193)
Net cash used in investing activity
(1,834)
(19,193)
Cash Flows from financing activities
Repayment to related party
(70,311)
0
Proceeds from related party
498,180
254,835
Repayment to borrowings
(66,134)
(74,689)
Net cash provided by financing activities
361,735
180,146
Effect of foreign currency translation on cash and cash equivalents
(46,446)
(2,211)
Net decrease of cash and cash equivalents
(3,862)
(5,972)
Cash and cash equivalents
Beginning
18,169
24,141
Ending
14,307
18,169
Cash paid during the periods for:
Interest
4,660
0
Income taxes
0
0
Non-cash financing and investing activities:
Related party debt converted to Common stock
345,000
Related party debt converted to Common stock
55,000
Compensation expense relating to issuance of restricted common stock
$ 41,019
Deferred compensation expense relating to issuance of restricted common stock
38,534
Deferred compensation expense relating to issuance of warrant
$ 2,140
v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets
Cash and cash equivalents
$ 14,307
$ 18,169
Accounts receivable
224,590
160,253
Inventory, net
79,482
46,196
Advances to suppliers
161,179
166,594
Security deposits
3,802
6,608
Prepaid expenses and other current assets
3,959
28,096
Total Current Assets
487,319
425,916
Non-Current Assets
Property, plant and equipment, net
5,660
4,692
Operating lease right of use asset
4,192
115,884
Total Non-Current Assets
9,852
120,576
Total Assets
497,171
546,492
Current Liabilities
Accounts payable
9,761
0
Other payable and accrued expenses
309,103
73,352
Due to shareholders
74,065
277,080
Income taxes payable
45,318
49,074
Other current liabilities
1,000,000
750,000
Operating lease liabilities - current
2,818
48,231
Current portion of long-term loan payables
53,165
68,497
Total Current Liabilities
1,494,230
1,266,234
Non-Current Liabilities
Long-term loan payables
65,210
116,012
Operating lease liabilities - non-current
1,374
80,538
Total Non-Current Liabilities
66,584
196,550
Total Liabilities
1,560,814
1,462,784
Commitments and Contingencies
Shareholders' Deficit
Preferred stock ($0.001 par value, 5,000,000 shares authorized, 1,500,000 shares issued and outstanding as of December 31, 2023 and 2022, respectively)
1,500
1,500
Common stock ($0.001 par value; 1,000,000,000 shares authorized, 604,781,560 and 183,781,560 shares issued and outstanding as of December 31, 2023 and 2022, respectively)
604,781
183,781
Additional paid in capital
175,268
67,249
Deferred stock compensation
(40,674)
(40,674)
Accumulated loss
(1,802,695)
(1,165,665)
Accumulated other comprehensive income (loss)
(1,823)
42,964
Total deficit attributable to EOS, Inc.
(1,063,643)
(910,845)
Non-controlling interest
0
(5,447)
Total Deficit
(1,063,643)
(916,292)
Total Liabilities and Shareholders' Deficit
$ 497,171
$ 546,492